School of Pharmacy, University of Eastern Finland, Faculty of Health Sciences, P.O. Box 1627, FI-70211 Kuopio, Finland.
J Chem Inf Model. 2012 Feb 27;52(2):457-64. doi: 10.1021/ci200432k. Epub 2012 Jan 25.
Constitutive androstane receptor (CAR), along with pregnane x receptor (PXR), is an important metabolic sensor in the hepatocytes. Like all other nuclear receptors (NRs), CAR works in concert with coregulator proteins, coactivators, and corepressors which bind to the NRs. The main basis for the receptor to distinguish between coactivators and corepressors is the position of the C-terminal helix 12 (H12), which is determined by the bound NR ligand. CAR, having constitutive activity, can be repressed or further activated by its ligands. Crystal structure of human CAR bound to an agonist and a coactivator peptide is available, but no structural information on an inverse agonist-bound human CAR and a corepressor exists. In our previous molecular dynamics (MD) studies, no corepressor peptide was included. Therefore, probably due to the strong interactions which keep the relatively short H12 of CAR in the active position, the structural changes elicited by inverse agonists were very subtle, and H12 of CAR seemed to more or less retain its active conformation. Here, we have run a series of MD simulations to study the movement of H12 in the presence of both activating and repressing ligands as well as a corepressor peptide. The presence of the corepressor on the coregulator surface of CAR induced a clear shift of H12 of the inverse agonists-bound CAR. In general, H12 moved toward H10 and not away from the ligand binding domain, as seen in some other NRs. However, H12 of CAR is short enough that this movement seems to be adequate to accommodate the binding of the corepressor.
组成型雄烷受体(CAR)与妊娠相关 X 受体(PXR)一样,是肝细胞中重要的代谢传感器。与所有其他核受体(NRs)一样,CAR 与共激活蛋白、共抑制蛋白协同作用,这些蛋白与 NRs 结合。受体区分共激活蛋白和共抑制蛋白的主要依据是 C 末端螺旋 12(H12)的位置,这由结合的 NR 配体决定。CAR 具有组成型活性,其配体可以抑制或进一步激活 CAR。已获得与激动剂和共激活肽结合的人 CAR 的晶体结构,但不存在与反向激动剂结合的人 CAR 和核心抑制剂的结构信息。在我们之前的分子动力学(MD)研究中,没有包含核心抑制剂肽。因此,可能由于保持 CAR 相对较短的 H12 处于活性位置的强相互作用,反向激动剂引起的结构变化非常细微,并且 CAR 的 H12 似乎或多或少保留其活性构象。在这里,我们进行了一系列 MD 模拟,以研究在激活和抑制配体以及核心抑制剂肽存在的情况下 H12 的运动。核心抑制剂在 CAR 共激活蛋白表面的存在诱导了反向激动剂结合的 CAR 的 H12 的明显移位。一般来说,H12 向 H10 移动,而不是远离配体结合域,就像在其他一些 NRs 中看到的那样。然而,CAR 的 H12 足够短,这种运动似乎足以容纳核心抑制剂的结合。